Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy
Condition(s) studied
Investigational drug(s) / intervention(s)
Prednisolone: prednisolone 60mg tablet once daily for 5 days then tapering dose
Cerebrolysin: intramuscular Cerebrolysin 10 mg daily for 3 weeks
Study summary
Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies.
Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy
Eligibility
Primary outcome measure(s)
- change in scores of the house Brackman grading system HB — at baseline, after 1 week, after 3 week
- changes in scores of the Sunnybrook grading system. — at baseline, after 1 week, after 3 week
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| October 6 university hospital | Giza | Egypt | Recruiting |
More October 6 University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05821075 on ClinicalTrials.gov ↗ ← All trials in Egypt